Effect of weight reduction on the severity of lower urinary tract symptoms in obese male patients with benign prostatic hyperplasia: A randomized controlled trial.
10.4111/kju.2015.56.3.240
- Author:
Chi Hang YEE
1
;
Wing Yee SO
;
Sidney KH YIP
;
Edwin WU
;
Phyllis YAU
;
Chi Fai NG
Author Information
1. Department of Surgery, The Chinese University of Hong Kong, Hong Kong, China. ngcf@surgery.cuhk.edu.hk
- Publication Type:Original Article ; Randomized Controlled Trial ; Research Support, Non-U.S. Gov't
- Keywords:
Exercise;
Lower urinary tract symptoms;
Obesity
- MeSH:
Adrenergic alpha-Antagonists/*therapeutic use;
Aged;
Body Mass Index;
Humans;
Lower Urinary Tract Symptoms/*drug therapy;
Male;
Middle Aged;
*Obesity;
Prospective Studies;
Prostatic Hyperplasia/diagnosis/*drug therapy;
Quality of Life;
Severity of Illness Index;
Treatment Outcome;
*Weight Loss
- From:Korean Journal of Urology
2015;56(3):240-247
- CountryRepublic of Korea
- Language:English
-
Abstract:
PURPOSE: We assessed whether weight reduction is an effective intervention for the management of lower urinary tract symptoms (LUTS) and investigated the relationship between obesity and LUTS. MATERIALS AND METHODS: This was a prospective randomized controlled trial that enrolled obese men older than 50 years with LUTS. The study period was 52 weeks. All patients received standardized alpha-adrenergic blocker therapy for the treatment of benign prostatic hyperplasia (BPH) during the run-in period. Patients were randomized to receive either a standardized prerecorded video program on the general principle of weight reduction or a comprehensive weight reduction program. Patients were assessed at different time points with symptom assessment, uroflowmetry, transrectal ultrasound, and metabolic assessment. RESULTS: Sixty-five patients were allocated to each study arm. After the study period, no significant difference in weight reduction was found between the two arms. When the pre- and postintervention parameters were compared, none were statistically different between the 2 arms, namely nocturia, International Prostate Symptom Score, quality of life assessment, and uroflowmetry parameters. When the whole study population was taken as a single cohort, these parameters were also not significantly different between the group with a body mass index of 25 to <30 kg/m2 and the group with a BMI of 30 to 35 kg/m2. CONCLUSIONS: We found no association between obesity and LUTS. This could have been due to the less marked weight difference in our cohort. Whereas weight reduction may be an effective measure to improve LUTS, the implementation of a successful program remains a challenge.
